Treats NSCLC and Pancreatic Cancer
FDA-approved active ingredient (Erlotinib)
Starts working within 4 hours of oral administration
Fast shipping
Dr. Akansha is a licensed Clinical Pharmacologist with extensive expertise in pharmacovigilance, prescription analysis, drug information, and safety. She's a dedicated educator and avid learner. Dr. Akansha also reviews medical content on GoodRxMedicine, ensuring accurate pharmaceutical information is accessible to all.
Julian, an MBA in Pharmaceutical Management, brings a dynamic blend of expertise and impact with his contributions at GoodRxMedicine. His dedication and innovative spirit continue to shape a brighter future in pharmaceutical management.
Krypton Erlotinib 150 mg is a targeted Cancer therapy used for Non-small cell Lung Cancer (NSCLC) and Pancreatic Cancer. It contains Erlotinib, a Tyrosine Kinase Inhibitor that inhibits the working of specific proteins that promote Cancer cell growth and spread.
This, in turn, helps to limit tumor development and improve patient outcomes. Krypton Global Health mainly manufactures the medication.
Krypton Erlotinib 150 uses include:
Erlotinib being a Tyrosine Kinase Inhibitor (TKI) exclusively targets the Epidermal Growth Factor Receptor (EGFR). EGFR is a protein present on the surface of specific cells that regulates cell growth and division. In some forms of Cancers, including Non-small Cell Lung Cancer (NSCLC) and Pancreatic Cancer, EGFR is hyperactive, resulting in uncontrolled cell proliferation.
Erlotinib binds to the specific EGFR Tyrosine Kinase's binding site, blocking its activation and inhibiting the downstream signaling flows essential for tumor growth and survival. This inhibition slows disease development, shrinks tumors, and improves survival outcomes in individuals with EGFR mutation-positive tumors.
Erlotinib effectively manages Non-small cell Lung Cancer and Pancreatic Cancer. It serves the following benefits:
Always follow your doctor’s advice while taking Krypton Erlotinib 150. Here are some common usage guidelines:
Krypton Erlotinib 150 tablet can lead to some potential side effects, including:
Most side effects tend to be mild and temporary, gradually fading as your body adjusts to the medication. However, consulting a healthcare professional without delay is crucial if they linger or worsen over time.
Certain medications, underlying health conditions, and specific dietary choices can influence the effectiveness of Krypton Erlotinib 150.
Knowing the following drug interactions is crucial to ensure their efficacy and minimize adverse effects:
The medications mentioned above are not the only ones that interact with Krypton. Consult your doctor for detailed advice.
Following diseases can interact with the mediation, influencing both its efficacy and safety profile:
When taking Krypton Erlotinib 150, it's essential to be aware of the following food interactions that can affect its effectiveness and safety:
Here are some necessary precautions to take while using this medication:
GoodRxMedicine is dedicated to delivering a secure, cost-effective, and hassle-free method to purchase medications online. Here's why you should entrust us with your healthcare needs:
No. It is not advisable to have herbal teas with the medication. Some herbal teas, particularly St. John's Wort, may affect the efficacy of Erlotinib. Always talk to your doctor before using any herbal supplements.
Yes. Mild pain relievers, such as Paracetamol, are generally safe. Still, Non-steroidal Anti-inflammatory Drugs (NSAIDs) like Ibuprofen and Aspirin should be avoided since they increase the risk of gastrointestinal bleeding.
No. Live immunizations should be avoided while having the medication, since Erlotinib might damage your immune system. Inactivated immunizations may be safer but talk to your doctor first before considering a treatment.
No. Erlotinib may impair wound healing and raise the risk of bleeding. Please inform your doctor before any operation, as they may recommend halting medication before and after the procedure to avoid difficulties. Always follow the doctor's advice for a safe procedure.
Yes. Erlotinib may cause skin changes such as hyperpigmentation, dryness, or rashes. Some people may experience acne-like outbreaks or an increased sensitivity to sunlight. Using moisturizers and sunscreen can help reduce discomfort. Consult your doctor if your skin reactions worsen.
inside review file